Clinical Gastroenterology Vol.25 No.3(9)

Theme Precancerous Conditions and Cancer High-risk Lesions in the Esophagus and the Stomach
Title Epstein-Barr Virus Infection and Gastric Cancer
Publish Date 2010/03
Author Jun Nishikawa Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Author Mari Saito Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Author Toshiyuki Okada Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine
Author Yuki Fukagawa Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Author Shu Kiyotoki Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Author Kouichi Hamabe Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Author Takeshi Okamoto Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Author Yutaka Suehiro Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine
Author Yuji Hinoda Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine
Author Isao Sakaida Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
[ Summary ] The Epstein-Barr virus(EBV) is detected in about 10% of gastric carcinoma cases throughout the world. In EBV-associated gastric carcinomas, all tumor cells harbor the clonal EBV genome. It is considered that EBV plays an important role in the development of EBV-associated gastric carcinomas. Most EBV-associated gastric carcinomas exhibit lymphocyte infiltration rich histology, which may indicate a relatively favorable prognosis in EBV-positive cases. The role of EBV in gastric epithelial oncogenesis is now being elucidated. Up-regulation of IGF1 (insulin-like growth factor 1) and DNA methylation of tumor suppressor genes may also be involved.
back